Dr Reddys Laboratories (RDY) Inventory (2009 - 2026)

Dr Reddys Laboratories has reported Inventory for 18 years, with the latest figure at $850.0 million in Q2 2026.

• On a quarterly basis, Inventory fell 3.78% year-over-year to $850.0 million in Q2 2026; TTM through Jun 2026 was $850.0 million, a 3.78% decrease from a year earlier, with the FY2026 full-year figure at $816.0 million, down 1.92% from the prior year.
• Inventory was $850.0 million for Q2 2026 at Dr Reddys Laboratories, up from $837.2 million in the prior quarter.
• The five-year high for Inventory was $887.2 million in Q4 2025, with the low at $592.1 million in Q1 2023.
• Average Inventory over 5 years is $758.5 million, with a median of $793.1 million recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Inventory slipped 12.51% in 2023, then gained 29.25% in 2024.
• Over 5 years, Inventory stood at $600.8 million in 2022, then grew by 21.53% to $730.2 million in 2023, then climbed by 16.19% to $848.4 million in 2024, then rose by 4.58% to $887.2 million in 2025, then dropped by 4.19% to $850.0 million in 2026.
• The last three Inventory figures came in at $850.0 million (Q2 2026), $837.2 million (Q1 2026), and $887.2 million (Q4 2025), per Business Quant data.